These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1517015)

  • 21. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
    Pletneva EV; Laederach AT; Fulton DB; Kostic NM
    J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absolute configuration for peptidomimetic residues in bioactive peptides.
    Yamazaki T; Goodman M
    Chirality; 1991; 3(4):268-76. PubMed ID: 1742164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC; Schiller PW
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
    Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T
    Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues.
    Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G
    Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topographical requirements for delta-selective opioid peptides.
    Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
    Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints.
    Naim M; Nicolas P; Baron D
    Int J Pept Protein Res; 1996 May; 47(5):353-60. PubMed ID: 8791158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn.
    Dyson HJ; Rance M; Houghten RA; Lerner RA; Wright PE
    J Mol Biol; 1988 May; 201(1):161-200. PubMed ID: 2843644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositol-3-OH kinase.
    Barchi JJ; Nomizu M; Otaka A; Roller PP; Burke TR
    Biopolymers; 1996 Feb; 38(2):191-208. PubMed ID: 8589253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge.
    Filip K; Oleszczuk M; Pawlak D; Wojcik J; Chung NN; Schillerc PW; Izdebski J
    J Pept Sci; 2003 Oct; 9(10):649-57. PubMed ID: 14620130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculations.
    Belleney J; Gacel G; Fournié-Zaluski MC; Maigret B; Roques BP
    Biochemistry; 1989 Sep; 28(18):7392-400. PubMed ID: 2554969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of cyclic and acyclic partial retro-inverso modified enkephalins.
    Berman JM; Goodman M
    Int J Pept Protein Res; 1984 Jun; 23(6):610-20. PubMed ID: 6469459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1H- and 13C-NMR investigations on cis-trans isomerization of proline peptide bonds and conformation of aromatic side chains in H-Trp-(Pro)n-Tyr-OH peptides.
    Poznański J; Ejchart A; Wierzchowski KL; Ciurak M
    Biopolymers; 1993 May; 33(5):781-95. PubMed ID: 8393714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid peptides. Partially modified retro-inverso dermorphin analogues. XIII.
    Marastoni M; Balboni G; Tomatis R; Salvadori S; Borea PA; Uccelli L
    Farmaco; 1989 Nov; 44(11):1083-93. PubMed ID: 2562001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.